Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Journal of Human Hypertension
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
September 1999, Volume 13, Number 9, Pages 617-623
Table of contents    Previous  Abstract  Next   Article  PDF
Original article
Left ventricular hypertrophy predicts outcome of hypertension regardless of the type of ventricular arrhythmia present
C de C Frimm, B M Trezza, C Gruppi, C C J Medeiros, M Cúri and E M Krieger

Heart Institute, School of Medicine, University of São Paulo, Brazil

Correspondence to: Clovis de Carvalho Frimm, Heart Institute, School of Medicine, University of São Paulo, Av. Dr.Eneas de Carvalho Aguiar, 44 05403-900 - São Paulo, SP, Brazil

Abstract

Left ventricular hypertrophy is associated with an increased cardiovascular mortality in hypertension. A potential role of ventricular arrhythmias is debated but not yet determined. The purpose of this study was to evaluate whether the presence of arrhythmias would ascribe any additional risk to cardiovascular mortality beyond that related to the presence of left ventricular hypertrophy. From November 1988 to February 1991, 40 mild to severe hypertensive patients (mean SBP, DBP 183/117 mm Hg) were submitted to clinical, echocardiographic and electrocardiographic evaluations complemented by 24-h Holter monitoring and then followed until November 1996. The Kaplan-Meier method supplemented by the Cox multiple regression model were performed to identify the variable(s) associated with fatal cardiovascular outcome. Twelve cardiovascular fatalities occurred as a consequence of sudden death (n = 4), stroke (n = 4), heart failure (n = 2) and myocardial infarction (n = 2). In comparison with patients who survived, those dying from cardiovascular causes had a greater percentage of electrocardiographic left ventricular hypertrophy (83 vs 36%, P = 0.0037) and couplets of ventricular ectopic beats (58 vs 18%, P = 0.0467). In addition, they showed larger left ventricular diastolic diameter (60 ± 10 vs 53 ± 8 mm), mass index (248 ± 67 vs 154 ± 57 g/m2) and posterior wall thickness (12 ± 2 vs 10 ± 2 mm), as well as shorter left ventricular fractional shortening (0.23 ± 0.8 vs0.32 ± 0.9). Univariate analysis showed that electrocardiographic left ventricular hypertrophy and strain, mass index, end-systolic wall stress, fractional shortening and the presence of couplets were significantly related to cardiovascular mortality. However, only mass index was shown to be independently associated with cardiovascular death. In conclusion, left ventricular hypertrophy predicts cardiovascular outcome, regardless of the presence of other signs of cardiac damage, including ventricular arrhythmia.

Keywords

hypertrophy; arrhythmias; cardiovascular mortality; echocardiography; Holter

Received 20 May 1999
September 1999, Volume 13, Number 9, Pages 617-623
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1999 Nature Publishing Group